Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-03-26
1988-09-27
Brown, J. R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 41, 536 174, 536 181, A61K 3170, C07H 1524
Patent
active
047742305
ABSTRACT:
Intestine-specific delivery of an opioid antagonist can be accomplished without substantial central nervous system effects by administering the antagonist orally in the form of the glucuronide derivative.
REFERENCES:
Fujimoto et al., Chemical Abstracts, vol. 71, 1969, p. 130, No. 37250y.
Fujimoto et al., Chemical Abstracts, vol. 72, 1970, p. 131, No. 98055f.
Dixon Ross
Smulkowski Maciej M.
Tuttle Ronald R.
Brown J. R.
Ivax Laboratories, Inc.
Peselev Elli
LandOfFree
Glucuronic acid derivatives of opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucuronic acid derivatives of opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucuronic acid derivatives of opioid antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398046